Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study

Fig. 2

SGLT2-inhibitors related adverse events among adults and older adults. Disproportionality analysis of SGLT2-inhibitors-related adverse events as compared to other non-insulin antidiabetic drugs from the full database. A lower limit of the adj.ROR 95% CI above 1 is the conventional threshold for significant signal detection. Adults are patients aged 18–75, older adults are 75 years or older. adj.ROR- Sex-adjusted reporting odds ratio; AKI- Acute kidney injury; CI- Confidence interval; DKA- Diabetic ketoacidosis; NIAD- non-insulin antidiabetic drugs; SGLT2- Sodium-glucose co-transporter 2

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840